levodopa carbidopa
Selected indexed studies
- Diagnosis and Treatment of Parkinson Disease: A Review. (JAMA, 2020) [PMID:32044947]
- Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease. (Drugs, 2019) [PMID:31549300]
- 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations. (CNS Drugs, 2021) [PMID:33582982]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Diagnosis and Treatment of Parkinson Disease: A Review. (2020) pubmed
- Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease. (2019) pubmed
- 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations. (2021) pubmed
- Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review. (2016) pubmed
- Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson's disease. (2020) pubmed
- Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson Disease. (2018) pubmed
- Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease. (2011) pubmed
- Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson's disease: a systematic review. (2025) pubmed
- The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson's Disease: A Systematic Review. (2020) pubmed
- Effect of levodopa/carbidopa on stress response in zebrafish. (2021) pubmed